KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia

Sujal R. Desai, Srihari Veeraraghavan, David M. Hansell et al. · Radiology · 2004 · 392 citations

Medicine, Clinical Sciences, Radiology +17

KL-6, a Mucin-like Glycoprotein, in Bronchoalveolar Lavage Fluid from Patients with Interstitial Lung Disease

Nobuoki Kohno, Yukikazu Awaya, Tetsu Oyama et al. · American Review of Respiratory Disease · 1993 · 292 citations

Medicine, Immunology, Pathology +17

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial

Dinesh Khanna, Carlo Albera, Aryeh Fischer et al. · The Journal of Rheumatology · 2016 · 269 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease

Jeong Seok Lee, Eun Young Lee, You‐Jung Ha et al. · Arthritis Research & Therapy · 2019 · 191 citations · Full text

Medicine, Internal Medicine, Radiology +17